News & Views

  • Merck Partners with Rigaku to Develop Novel Molecular Structure Analysis Technology  

Merck Partners with Rigaku to Develop Novel Molecular Structure Analysis Technology  

Jun 06 2019 Read 842 Times

Merck, a leading science and technology company, and Rigaku Corporation, a key player in scientific analytical instrumentation, have signed a joint development agreement to develop lab consumables based on highly innovative crystalline sponge technology, which determines the absolute chemical structure of organic molecules and enables X-ray crystallography without crystallisation of the analyte. 

“Rigaku has been at the leading edge of technology in the high-end crystallography market for decades. This project will open new doors for scientists at all levels of expertise across a range of disciplines - in medicine, life science and the evolution of advanced materials,” said Yoshiaki Watanabe, Senior Executive VP at Rigaku. 

“We have licensed a new technology with the potential to help labs determine absolute chemical structure quickly, even for samples on a sub-microgram scale. Our innovation project is working on dedicated consumables that will simplify the technology to enable our customers to apply it,” said Isabel De Paoli, Chief Strategy Officer at Merck. “With Rigaku, we have found an extremely competent partner to develop the best devices for the technology, and we are looking forward to working together on this project.” 

The project simplifies the complex technology and makes it available to chemical and life science laboratories working with pharmaceuticals, fine chemicals or natural compounds that need to determine the molecular structure of substances. 

The inventor of the technology, Dr Makoto Fujita, Distinguished Professor of the University of Tokyo and the Institute for Molecular Science, continues to be involved in the project through the University of Tokyo and the Japanese Science and Technology Agency. 

The partnership will combine both Rigaku’s proven success in the crystalline sponge area as a manufacturer and distributor of X-ray systems with Merck’s unique knowledge of innovative life science products and the analytical consumable market. 

The project is hosted at the Rigaku’s headquarters in Tokyo, where expert scientists and engineers are hard at work designing the next-generation instruments for turn-key solutions and at the Merck Innovation Center, which aims to create new products beyond Merck’s current businesses. 
 

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment




Digital Edition

Lab Asia December 2019

December 2019

In This Edition Mass Spectrometry & Spectroscopy - Translating Proteomic MALDi Tissue Typing to Clinical Pathology - Fusion Protein Complexes Analysed by CG-MALS - Non-equivalent, Multivalen...

View all digital editions

Events

SLAS 2020

Jan 25 2020 San Diego, CA, USA

Arab Health

Jan 27 2020 Dubai, UAE

Nano Tech 2020

Jan 29 2020 Tokyo, Japan

MEDLAB MIDDLE EAST

Feb 03 2020 Dubai, UAE

Smart Factory Expo (SFE 2020)

Feb 12 2020 Tokyo, Japan

View all events